e-space
Manchester Metropolitan University's Research Repository

    Items where Author is "Aballéa, Samuel"

    Up a level
    Export as [feed] Atom [feed] RSS
    Group by: Item Type | No Grouping
    Number of items: 3.

    Kragh, Nana Tytula, Anna Pochopien, Michał Aballéa, Samuel Toumi, Mondher Hakimi, Zalmai Nazir, Jameel et al.
    Kragh, Nana, Tytula, Anna, Pochopien, Michał, Aballéa, Samuel, Toumi, Mondher, Hakimi, Zalmai, Nazir, Jameel, Bystrická, Linda and Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953
    (2023) Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK. European Journal of Haematology, 110 (3). pp. 262-270. ISSN 0902-4441

    Mancuso, Maria Elisa ORCID logoORCID: https://orcid.org/0000-0002-7113-4028 Castaman, Giancarlo ORCID logoORCID: https://orcid.org/0000-0003-4973-1317 Pochopien, Michal Aballéa, Samuel Drzewiecka, Aleksandra ORCID logoORCID: https://orcid.org/0000-0003-3396-8571 Hakimi, Zalmai ORCID logoORCID: https://orcid.org/0000-0001-5835-8599 Nazir, Jameel et al.
    (2022) Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe. Journal of Medical Economics, 25 (1). pp. 1068-1075. ISSN 1369-6998

    Pasi, John ORCID logoORCID: https://orcid.org/0000-0003-3394-2099, Hermans, Cédric ORCID logoORCID: https://orcid.org/0000-0001-5429-8437, Hakimi, Zalmai, Nazir, Jameel, Aballéa, Samuel, Ezzalfani, Monia and Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953 (2022) Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study. Therapeutic Advances in Hematology, 13. pp. 1-9. ISSN 2040-6207

    This list was generated on Sat Dec 21 06:13:00 2024 GMT.